15Dec
Life Sciences Dealmaking Symposium: Powering through the Pandemic: Trends in Early-Stage Investment
The pursuit of progress during these unprecedented times has led to a surge in life sciences investment and funding for early stage companies. Investors are on the lookout for the next big innovation while also navigating new ways of sourcing and managing portfolio companies. Our panel of experienced early-stage investors discussed the top trends in this push for advancement, including sectors attracting the most dollars in today’s challenging business landscape, key issues that early stage...
By:
McDermott Will & Emery
Related
New ANSI standards are going into effect March 1, 2020, for aerial work platforms. It is important t...
Read More >
COVID-19 is likely to reshape the competitive landscape for many industries, including triggering in...
Read More >
On the heels of the U.S. Women’s Soccer Team’s World Cup win, Governor Andrew Cuomo on July 10, 20...
Read More >
As is the case in most merger transactions, both the buyer and seller retain their own counsel. Gene...
Read More >
In an age where computer generated imagery (CGI) and digital effects enable entire film genres to ex...
Read More >
As the coronavirus outbreak continues to have significant impacts globally, companies face issues th...
Read More >